Santen Pharmaceutical Co., Ltd. held its 111th Annual General Meeting of Shareholders for the fiscal year 2022 on June 27, 2023.The Meeting started at 10:00 a.m. and ended at 10:52 a.m. The number of shareholders attended was 57.
- Reports on Business Report, Consolidated Financial Statements and Non-consolidated Financial Statements for the 111th Business Term (April 1, 2022 to March 31, 2023)
- Reports on the Audit Reports by the Accounting Auditors and the Board of Corporate Auditors on the consolidated Financial Statements for the 111th Business Term (April 1, 2022 to March 31, 2023)
We received questions regarding the following subjects from shareholders in advance and answered each question on the meeting.
- The reason for the resignation of Previous President, and the responsibility for the nomination
- The reason for the impairment loss of the US Business, and the plan in the future
- Appointment of Female Director
- Status of current stock price
- Risk on China Business
We received questions regarding the following subjects from 3 shareholders attended and responded in kind.
- Lively discussion on the Board of Directors
- Situation of compliance, harassment
- Reason for the impairment loss, action, and its preventive measures
|Matters resolved||Three proposals were all resolved.|
Please refer to the Resolution Notice (PDF: 108KB)PDF file.Page will open in a new window. for detailed resolutions.